(Q38011775)

English

Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials

scientific article published on 07 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

0 references

Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

superficial basal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

M H Roozeboom

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

A H H M Arits

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

P J Nelemans

3

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

N W J Kelleners-Smeets

4

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

language of work or name

0 references

publication date

7 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

167

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

733-756

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Predictions of skin cancer incidence in the Netherlands up to 2015.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Epidemiology and aetiology of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Risk factors for single and multiple basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Guidelines for the management of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Trends in the incidence of basal cell carcinoma by histopathological subtype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

A systematic review of treatment modalities for primary basal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Commentary: Assessing the quality of observational studies--or a lesson from Mars

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Comparison of aminolevulinic acid (ALA)-thermogel-PDT with methyl-ALA-thermogel-PDT in basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Treatment of cutaneous tumors with topical 5% imiquimod cream.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Vascular based non conventional dye laser treatment for basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

5% imiquimod cream for the treatment of large superficial basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Topical photodynamic therapy at low fluence rates--theory and practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ with a high-energy pulsed carbon dioxide laser

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11061.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2012.11061.X

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38011775&oldid=2169009196"